
Akttyva Therapeutics develops targeted treatments for cell barrier dysfunction across various indications.
Akttyva Therapeutics, founded with the mission to revolutionize treatment for cell barrier dysfunction, focuses on developing targeted therapeutics for a range of medical indications. The company aims to address critical gaps in healthcare by offering innovative solutions that enhance cell barrier integrity, thereby improving patient outcomes across multiple conditions.
Notable individuals affiliated with Akttyva Therapeutics include leading experts in biotechnology and pharmaceutical development. The company has garnered attention from prominent investors in the healthcare sector, reflecting confidence in its potential. Key achievements include successful preclinical trials and strategic partnerships that have accelerated its research and development efforts, positioning Akttyva as a significant player in the field of targeted therapeutics.
Attivare Therapeutics

Tactiva Therapeutics

Actuate Therapeutics

Aktivax
aktivax.com

Actio Biosciences
actiobio.com

Therapyx
therapyxinc.com

Applied Therapeutics

Theradaptive
theradaptive.com

Entrada Therapeutics
entradatx.com

Guardian Therapeutics

Adcentrx Therapeutics
adcentrx.com

Aktis Oncology
aktisoncology.com

Actym Therapeutics
actymthera.com

Amplifier Therapeutics
amplifier-tx.com

Oviva Therapeutics
ovivatx.com
Companies similar to Akttyva Therapeutics include Attivare Therapeutics, Tactiva Therapeutics, Actuate Therapeutics and Aktivax.
Akttyva Therapeutics was founded in 2006.
Akttyva Therapeutics' headquarters is located in Mansfield, MA, US.
Akttyva Therapeutics' most recent funding round was for $255.5k (USD) in November 2021.
As of Nov 30, 2021, Akttyva Therapeutics has raised a total of $255.5k (USD).
Akttyva Therapeutics has 5 employees as of Feb 5, 2024.